Atossa Therapeutics
ATOS
#10731
Rank
C$33.39 M
Marketcap
C$3.35
Share price
-2.86%
Change (1 day)
154.44%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -C$52.48 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$48.89 Million a decrease over its 2024 earnings that were of -C$35.86 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$52.48 Million7.33%
2025 -C$48.89 Million36.33%
2024 -C$35.86 Million-15.25%
2023 -C$42.32 Million11.62%
2022 -C$37.91 Million30.84%
2021 -C$28.98 Million15.58%
2020 -C$25.07 Million3.41%
2019 -C$24.24 Million51.16%
2018 -C$16.04 Million40.41%
2017 -C$11.43 Million27.54%
2016 -C$8.96 Million-47.49%
2015 -C$17.06 Million-17.25%
2014 -C$20.61 Million35.91%
2013 -C$15.17 Million112.3%
2012 -C$7.15 Million46.53%
2011 -C$4.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.84 B-69,600.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$1.97 B-3,823.25%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$2.05 B-3,974.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
C$58.6 M-210.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-C$73.07 Million 37.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-C$11.03 Million-79.21%๐Ÿ‡บ๐Ÿ‡ธ USA